Machine-Learning-Based Identification of Key Feature RNA-Signature Linked to Diagnosis of Hepatocellular Carcinoma
Marwa Matboli1, Gouda I Diab2, Maha Saad3
1Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine Ain Shams University, Cairo 11566, Egypt.
Insights
A new machine learning model accurately predicts hepatocellular carcinoma (HCC) using RNA signatures and lab data. This RNA signature-based diagnostic tool shows promise for early HCC detection and improved patient outcomes.
Area of Science:
- Oncology
- Bioinformatics
- Machine Learning
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
- Early and accurate diagnosis of HCC is critical for patient prognosis and treatment efficacy.
- Developing novel diagnostic tools for HCC is a significant unmet need.
Purpose of the Study:
- To develop a machine learning model for HCC diagnosis.
- To integrate differentially expressed RNA signatures with laboratory parameters.
- To create a novel RNA signature-based diagnostic model for HCC.
Main Methods:
- Utilized five machine learning classifiers: KNN, RF, SVM, LGBM, and DNNs.
- Trained and tested models on 187 and 80 samples, respectively.
- Included 22 features: clinical data and specific RNA expression levels (e.g., miR-1298, miR-1262, RAB11A, STAT1).
Main Results:
- The LGBM classifier achieved the highest accuracy (98.75%) in HCC prediction.
- LGBM outperformed other models including Random Forest (96.25%) and DNN (91.25%).
- The model demonstrated high predictive performance for hepatocellular carcinoma.
Conclusions:
- The developed machine learning model, integrating RNA signatures and clinical data, shows potential as a novel diagnostic tool for HCC.
- Specific RNA signatures (RAB11A, STAT1, ATG12, miR-1262, etc.) are key components of the diagnostic model.
- This approach offers a promising avenue for early and accurate HCC detection.
Background:
Hepatocellular carcinoma (HCC) is the third prime cause of malignancy-related mortality worldwide. Early and accurate identification of HCC is crucial for good prognosis, efficacy of therapy, and survival rates of the patients. We aimed to develop a machine-learning model incorporating differentially expressed RNA signatures with laboratory parameters to construct an RNA signature-based diagnostic model for HCC.
Methods:
We have used five classifiers (KNN, RF, SVM, LGBM, and DNNs) to predict the liver disease (HCC). The classifiers were trained on 187 samples and then tested on 80 samples. The model included 22 features (age, sex, smoking, cirrhosis, non-cirrhosis, albumin, ALT, AST bilirubin (total and direct), INR, AFP, HBV Ag, HCV Abs, RQmiR-1298, RQmiR-1262, RQmiR-106b-3p, RQmRNARAB11A, and RQSTAT1, RQmRNAATG12, RQLnc-WRAP53, RQLncRNA- RP11-513I15.6).
Results:
LGBM achieved the highest accuracy of 98.75% in predicting HCC among all models surpassing Random Forest (96.25%), DNN (91.25%), SVC (88.75%), and KNN (87.50%).
Conclusion:
Our machine-learning model incorporating the expression data of RAB11A/STAT1/ATG12/miR-1262/miR-1298/miR-106b-3p/lncRNA-RP11-513I15.6/lncRNA-WRAP53 signature and clinical data represents a potential novel diagnostic model for HCC.
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
